Gravity Medical Technology

1/🌐 The Gravity Mission: Born from a 🌍 collective of stroke experts in neuroimaging, neuroendovascular surgery, clinical trials & medical device development, the Gravity Mission is rewriting the story of stroke care. Our mission is clear: we're uniting to transform stroke tx

As highlighted in this summary, treatment decisions are no longer based on time alone, but on a combination of imaging, clinical status, and individual patient factors. #gravityconnect #stroke #thrombectomy

Key updates include: • Strong evidence for EVT in patients with ASPECTS 3–10 (within 6 hours) • Continued benefit in the 6–24 hour window with appropriate selection • Consideration of patients with low ASPECTS, including very large core, in selected cases

AHA/ASA 2026 Stroke Guideline Update - EVT in Anterior Circulation by Prof. Ashutosh Jadhav⁩ The approach to thrombectomy is shifting toward treating more patients. Across time windows, imaging profiles, & patient factors, the latest guidance expands who may benefit from EVT.

Missed it live? Here’s a glimpse of a timely and powerful conversation on early management of acute ischemic stroke and the 2026 AHA/ASA guideline insights with Dr. @AshuPJadhav

Gravity will be at INSC 2026, the 19th Annual Conference of the Indian Stroke Association, at Grand Hyatt Kochi from March 13–15, 2026. Meet our team to explore how next‑gen thrombectomy technology can enhance your clinical practice in the most challenging stroke scenarios

We are thrilled to announce the successful close of our Series A financing round. This reflects strong confidence in our long-term vision supporting key priorities, including securing regulatory approvals, expanding manufacturing capacity, & accelerating the commercial readiness.

We're thrilled to announce Stephen Chu's appointment to Gravity's Board of Directors. As Chief Legal and Administrative Officer at InStride, he brings invaluable expertise in corporate governance and scaling high-growth organizations. Join us in welcoming Stephen to the team.

GravityConnect: Early Management of AIS 2026 AHA/ASA Guideline Insights with Prof. Ashutosh Jadhav In collaboration with Bangkok Hospital Pattaya. A focused discussion on translating the latest guidelines into real-world stroke care. Part of our ongoing expert series.

@GravityMedTech @AshuPJadhav @dyavagal @ShashvatDesai @KunakornAt Acute brain #stroke Nice device Great results #supernova #gravity

A sincere thank you to Dr. Madan Mohan Gupta @madannohangupta for your leadership, trust, and commitment to advancing stroke care. We’re proud to partner with you in bringing innovative treatment options to patients who need them most. #StrokeCareForAll #GRASSROOTregistry

Gravity devices now available in India through Estara MedTech Get in touch: info@estaramed.com admin@gravitymedtech.com #GravityMedicalTechnology #Supernova #Neutron #StrokeCareForAll #StrokeCareIndia #Thrombectomy #Neurointervention #MedicalDevicesIndia #EstaraMedTech

Celebrating Supernova's launch in India! #SupernovaLaunch #StrokeCareIndia #GRASSROOTTrial #NeurovascularInnovation #CDSCOApproved #GravityMedTech #MechanicalThrombectomy #SaveLivesIndia

Catch our Global Executive Manager's talk in the Entrepreneurship Management Series for National Startup Day 2026 today, 3-3:30 PM at BVR Scient, IIT Hyderabad

Supernova Stent Retriever – our revolutionary neurovascular device for effective stroke clot removal – officially launches in India on January 23rd, 2026! #SupernovaLaunch #StrokeCare #GravityMedTech #Neurovascular #IndiaHealthcare

Championing stroke innovation across the world in 2025. From landmark GRASSROOT Trial milestones to global conferences, every step brought us closer to accessible stroke care. Grateful to everyone for being part of this journey. (2/2) #GravityMedicalTechnology #yearinreview

Championing stroke innovation across the world in 2025. From landmark GRASSROOT Trial milestones to global conferences, every step brought us closer to accessible stroke care. Grateful to everyone for being part of this journey. (1/2) #GravityMedicalTechnology #yearinreview